http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2356561-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6e0e7dc1062b9cde54f2b6279f360ef |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-721 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_012a2812d4e6d397b241997b33c1aa99 |
| publicationDate | 2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2356561-C1 |
| titleOfInvention | Intravenous droplet composition based on purified placenta hydrolysate (versions) |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to chemical-pharmaceutical industry, medicine and cosmetology, and concerns an agent for liver pathologies, as well as for improved skin colour and structure, lassitude relief, higher immune protection function, intensified sexual function. The composition contains Laennec, a solution containing ammonium glycyrrhizinate, glycine, L cysteine, 20% dextrose solution ("ничифарген"), vitamin B1, B2, B6, B12, C solutions, physiologic saline. Another version of the composition contains Laennec, 20% dextrose solution, vitamin B1, B2, B6, B12, C solutions, physiologic saline. The compositions are intravenously droplet introduced while providing complex action practically without by-effects. n EFFECT: composition effectiveness is ensured with synergetic action of all the components. n 2 cl, 9 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2599040-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2709229-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2488376-C1 |
| priorityDate | 2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 99.